Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
1University Children's Hospital, Ulm, Germany. simone.fulda@uniklinik-ulm.de
Oncogene
|August 8, 2006
Summary
Apoptosis, or programmed cell death, is vital for controlling tissue growth and responding to cancer treatments. Understanding how cancer cells evade apoptosis is key to developing new targeted cancer therapies.
Area of Science:
- Cancer Biology
- Cell Death Mechanisms
- Molecular Oncology
Background:
- Apoptosis regulates physiological growth and tissue homeostasis.
- Apoptosis is crucial in tumor formation and determines cancer treatment response.
- Current anticancer strategies rely on activating apoptosis pathways in tumor cells.
Purpose of the Study:
- To understand molecular events regulating apoptosis in response to chemotherapy.
- To investigate how cancer cells evade apoptotic death.
- To identify opportunities for developing molecular-targeted cancer therapies.
Main Methods:
- Analysis of apoptosis signal transduction pathways (intrinsic and extrinsic).
- Investigation of molecular mechanisms of cancer cell resistance to apoptosis.
- Review of current anticancer strategies linked to apoptosis activation.
Main Results:
- Failure to undergo apoptosis can lead to treatment resistance.
- Understanding evasion mechanisms offers therapeutic targets.
- Apoptosis activation is central to efficacy of chemotherapy, irradiation, gene, and immunotherapies.
Conclusions:
- Targeting apoptosis evasion is a promising strategy for novel cancer therapies.
- Molecular understanding of apoptosis is essential for rational drug development.
- Enhanced apoptosis induction in cancer cells can overcome treatment resistance.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...